Bonifacio Nicolas Díaz-Chico
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Bonifacio Nicolas Díaz-Chico has a total of 189 co-authors. Here are the top co-authors by number of shared publications:
- Juan Carlos Díaz Chico
Endometrial Cancer Study Group, Instituto Canario de Investigación del Cáncer (ICIC), Canary Islands, Spain
20 shared publications - Leandro Fernández-Pérez
Instituto Universitario de Investigaciones Biomédicas y Sanitarias (IUIBS), Farmacología Molecular y Traslacional, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain
18 shared publications - Francisco German Rodriguez Gonzalez
Biotech Research and Innovation Center (BRIC), University of Copenhagen , Copenhagen
15 shared publications Ricardo Chirino
The Department of Biochemistry and Physiology, Universidad de Las Palmas de Gran Canaria, Canary Islands, Spain
9 shared publications- Cristina Bilbao-Sieyro
Hospital Universitario de Gran Canaria Dr. Negrín, Instituto de Investigación Sanitaria de Canarias (IISC), Las Palmas De Gran Canaria, Spain
8 shared publications Domingo Navarro
Department of Biochemistry, Instituto Canario de Investigación del Cáncer (ICIC), P.O. Box 550, 35080 Las Palmas de Gran Canaria, Canary Islands, Spain
7 shared publications
Latest Publications
- 1 March 2019
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 39 (5)
Common and Differential Transcriptional Actions of Nuclear Receptors Liver X Receptors α and β in Macrophages
The liver X receptors, LXRα and LXRβ, are oxysterol-activated transcription factors that coordinately regulate gene expression important for cholesterol and fatty acid metabolism. In addition to their roles in lipid metabolism, LXRs participate in the transcriptional regulation of macrophage activation and are considered potent regulators of inflammation. LXR receptors are highly similar and, despite notable exceptions, most of their reported functions are substantially overlapping. However, their individual genomic distribution and transcriptional capacities have not been characterized. Here we report a macrophage cellular model expressing equivalent levels of tagged LXRs. ChIP-seq data analysis revealed that LXRα and LXRβ occupy both overlapping and exclusive genomic regulatory sites of target genes and also control the transcription of a receptor-exclusive set of genes. Analysis of genomic H3K27 acetylation and mRNA transcriptional changes in response to synthetic agonist or antagonist treatments revealed a putative mode of pharmacological-independent regulation of transcription. Integration of microarray and sequencing data enabled the description of three possible mechanisms of LXR transcriptional activation. Together, these results contribute to our understanding of the common and differential genomic actions of LXRs and their impact on biological processes in macrophages.
- 1 March 2019
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 39 (5)
Common and Differential Transcriptional Actions of Nuclear Receptors Liver X Receptors α and β in Macrophages
The liver X receptors, LXRα and LXRβ, are oxysterol-activated transcription factors that coordinately regulate gene expression important for cholesterol and fatty acid metabolism. In addition to their roles in lipid metabolism, LXRs participate in the transcriptional regulation of macrophage activation and are considered potent regulators of inflammation. LXR receptors are highly similar and, despite notable exceptions, most of their reported functions are substantially overlapping. However, their individual genomic distribution and transcriptional capacities have not been characterized. Here we report a macrophage cellular model expressing equivalent levels of tagged LXRs. ChIP-seq data analysis revealed that LXRα and LXRβ occupy both overlapping and exclusive genomic regulatory sites of target genes and also control the transcription of a receptor-exclusive set of genes. Analysis of genomic H3K27 acetylation and mRNA transcriptional changes in response to synthetic agonist or antagonist treatments revealed a putative mode of pharmacological-independent regulation of transcription. Integration of microarray and sequencing data enabled the description of three possible mechanisms of LXR transcriptional activation. Together, these results contribute to our understanding of the common and differential genomic actions of LXRs and their impact on biological processes in macrophages.
- Open Access
- 14 August 2018
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (63) , 32272
Correction: CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia
[This corrects the article DOI: 10.18632/oncotarget.11425.].
- 14 August 2018
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (63) , 32272
Open AccessCorrection: CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia
[This corrects the article DOI: 10.18632/oncotarget.11425.].
- Open Access
- 14 September 2017
- Published by ARAN Ediciones in Nutrición Hospitalaria
- Vol. 34 (5) , 1089-1098
Androgen receptor gene polymorphisms and maximal fat oxidation in men. A longitudinal study.
Introduction: The aims of this study were i) to evaluate if extreme CAG and GGN repeat polymorphisms of the androgen receptors (AR) influence body fat mass, its regional distribution, resting metabolic rate (RMR), resting and maximal fat oxidation capacity (MFO) and fat tissue accumulation after 6.4 years of follow up and ii) to determine if these differences are explained by changes in maximal oxygen uptake (VO2max).Potential associations between AR polymorphisms and serum concentration of leptin, free testosterone and osteocalcin were also examined. Methods: CAG and GGN repeats length were measured in 319 men (mean±SD: 28.3±7.6 years). From these, we selected the subjects with extreme short (CAGS≤19; n=7) and long (CAGL≥24; n=10) CAG repeats, and the subjects with short (GGNS≤22; n=9) and long (GGNL≥25; n=10) GGN repeats. Results: CAGS and CAGL subjects had similar RMR and accumulated comparable amounts of fat tissue over 6.4 ± 1.0 years of follow-up. However, CAGL showed higher MFO and total lean mass than CAGS (pS accumulated greater amount of total fat mass than men with GGNL, particularly in the trunk region seven years later. This concurs with a trend for a greater MFO in the GGNL group (P=0.06), who accumulated less fat mass. Free testosterone was associated with MFO in absolute values (r=0.45; p<0.05) and MFO per kg of lower extremity lean mass per height squared (r=0.35; p<0.05). Conclusions:CAG and GGN repeats polymorphisms may influence muscle fat oxidation capacity and may have a role in the accumulation of fat over the years.
- 14 September 2017
- Published by ARAN Ediciones in Nutrición Hospitalaria
- Vol. 34 (5) , 1089-1098
Open AccessAndrogen receptor gene polymorphisms and maximal fat oxidation in men. A longitudinal study.
Introduction: The aims of this study were i) to evaluate if extreme CAG and GGN repeat polymorphisms of the androgen receptors (AR) influence body fat mass, its regional distribution, resting metabolic rate (RMR), resting and maximal fat oxidation capacity (MFO) and fat tissue accumulation after 6.4 years of follow up and ii) to determine if these differences are explained by changes in maximal oxygen uptake (VO2max).Potential associations between AR polymorphisms and serum concentration of leptin, free testosterone and osteocalcin were also examined. Methods: CAG and GGN repeats length were measured in 319 men (mean±SD: 28.3±7.6 years). From these, we selected the subjects with extreme short (CAGS≤19; n=7) and long (CAGL≥24; n=10) CAG repeats, and the subjects with short (GGNS≤22; n=9) and long (GGNL≥25; n=10) GGN repeats. Results: CAGS and CAGL subjects had similar RMR and accumulated comparable amounts of fat tissue over 6.4 ± 1.0 years of follow-up. However, CAGL showed higher MFO and total lean mass than CAGS (pS accumulated greater amount of total fat mass than men with GGNL, particularly in the trunk region seven years later. This concurs with a trend for a greater MFO in the GGNL group (P=0.06), who accumulated less fat mass. Free testosterone was associated with MFO in absolute values (r=0.45; p<0.05) and MFO per kg of lower extremity lean mass per height squared (r=0.35; p<0.05). Conclusions:CAG and GGN repeats polymorphisms may influence muscle fat oxidation capacity and may have a role in the accumulation of fat over the years.
- 1 January 2017
- Published by Edizioni Minerva Medica in The Journal of Sports Medicine and Physical Fitness
- Vol. 57 (1-2) , 18-25
Androgen receptor CAG and GGN repeat polymorphisms influence performance in boys and girls
Article: Androgen receptor CAG and GGN repeat polymorphisms influence performance in boys and girls - The Journal of Sports Medicine and Physical Fitness 2017 January-February;57(1-2):18-25 - Minerva Medica - Journals
- 1 January 2017
- Published by Edizioni Minerva Medica in The Journal of Sports Medicine and Physical Fitness
- Vol. 57 (1-2) , 18-25
Androgen receptor CAG and GGN repeat polymorphisms influence performance in boys and girls
Article: Androgen receptor CAG and GGN repeat polymorphisms influence performance in boys and girls - The Journal of Sports Medicine and Physical Fitness 2017 January-February;57(1-2):18-25 - Minerva Medica - Journals
- Open Access
- 19 August 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (18) , 29679-29698
CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Borja Guerra1, 2, 3, *, Patricia Martín-Rodríguez1, *, Juan Carlos Díaz-Chico1, 3, Grant McNaughton-Smith4, Sandra Jiménez-Alonso3, 7, Idaira Hueso-Falcón4, Juan Carlos Montero5, Raquel Blanco6, Javier León6, Germán Rodríguez-González4, Ana Estévez-Braun3, 7, Atanasio Pandiella5, Bonifacio Nicolás Díaz-Chico1, 3, 4, Leandro Fernández-Pérez1, 3 1Instituto de Investigaciones Biomédicas y Sanitarias (IUIBS)-BioPharm Laboratory-Universidad de Las Palmas de Gran Canaria, Epaña 2Unidad de Apoyo a la Docencia en Enfermería-Fuerteventura, Universidad de Las Palmas de Gran Canaria, España 3Instituto Canario de Investigación sobre el Cáncer (ICIC), España 4Centro Atlántico del Medicamento (CEAMED), España 5Centro de Investigación del Cáncer, CSIC-Universidad de Salamanca, España 6Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), España 7Departamento de Química Orgánica, Instituto de Bio-Orgánica Antonio González (CIBICAN), Universidad de la Laguna, España *These authors contributed equally to this work Correspondence to: Leandro Fernández-Pérez, email: leandrofco.fernandez@ulpgc.es Keywords: leukemia, naphthoquinone, Bcrl-Abl-Stat5, imatinib resistance Received: April 23, 2016 Accepted: July 28, 2016 Published: August 19, 2016
- 19 August 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (18) , 29679-29698
Open AccessCM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Borja Guerra1, 2, 3, *, Patricia Martín-Rodríguez1, *, Juan Carlos Díaz-Chico1, 3, Grant McNaughton-Smith4, Sandra Jiménez-Alonso3, 7, Idaira Hueso-Falcón4, Juan Carlos Montero5, Raquel Blanco6, Javier León6, Germán Rodríguez-González4, Ana Estévez-Braun3, 7, Atanasio Pandiella5, Bonifacio Nicolás Díaz-Chico1, 3, 4, Leandro Fernández-Pérez1, 3 1Instituto de Investigaciones Biomédicas y Sanitarias (IUIBS)-BioPharm Laboratory-Universidad de Las Palmas de Gran Canaria, Epaña 2Unidad de Apoyo a la Docencia en Enfermería-Fuerteventura, Universidad de Las Palmas de Gran Canaria, España 3Instituto Canario de Investigación sobre el Cáncer (ICIC), España 4Centro Atlántico del Medicamento (CEAMED), España 5Centro de Investigación del Cáncer, CSIC-Universidad de Salamanca, España 6Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), España 7Departamento de Química Orgánica, Instituto de Bio-Orgánica Antonio González (CIBICAN), Universidad de la Laguna, España *These authors contributed equally to this work Correspondence to: Leandro Fernández-Pérez, email: leandrofco.fernandez@ulpgc.es Keywords: leukemia, naphthoquinone, Bcrl-Abl-Stat5, imatinib resistance Received: April 23, 2016 Accepted: July 28, 2016 Published: August 19, 2016
- Open Access
- 4 December 2015
- Published by Wiley in Scandinavian Journal of Medicine & Science in Sports
- Vol. 26 (11) , 1313-1320
Androgen receptor gene polymorphism influence fat accumulation: A longitudinal study from adolescence to adult age
To determine the influence of androgen receptor CAG and GGN repeat polymorphisms on fat mass and maximal fat oxidation (MFO), CAG and GGN repeat lengths were measured in 128 young boys, from which longitudinal data were obtained in 45 of them [mean ± SD: 12.8 ± 3.6 years old at recruitment, and 27.0 ± 4.8 years old at adult age]. Subjects were grouped as CAG short (CAGS) if harboring repeat lengths ≤ 21, the rest as CAG long (CAGL); and GGN short (GGNS) if GGN repeat lengths ≤ 23, or long if > 23 (GGNL). CAGS and GGNS were associated with lower adiposity than CAGL or GGNL (P < 0.05). There was an association between the logarithm of CAG repeats polymorphism and the changes of body mass (r = 0.34, P = 0.03). At adult age, CAGS men showed lower accumulation of total body and trunk fat mass, and lower resting metabolic rate (RMR) and MFO per kg of total lean mass compared with CAGL (P < 0.05). GGNS men also showed lower percentage of body fat (P < 0.05). In summary, androgen receptor CAG and GGN repeat polymorphisms are associated with RMR, MFO, fat mass, and its regional distribution in healthy male adolescents, influencing fat accumulation from adolescence to adult age.
- 4 December 2015
- Published by Wiley in Scandinavian Journal of Medicine & Science in Sports
- Vol. 26 (11) , 1313-1320
Open AccessAndrogen receptor gene polymorphism influence fat accumulation: A longitudinal study from adolescence to adult age
To determine the influence of androgen receptor CAG and GGN repeat polymorphisms on fat mass and maximal fat oxidation (MFO), CAG and GGN repeat lengths were measured in 128 young boys, from which longitudinal data were obtained in 45 of them [mean ± SD: 12.8 ± 3.6 years old at recruitment, and 27.0 ± 4.8 years old at adult age]. Subjects were grouped as CAG short (CAGS) if harboring repeat lengths ≤ 21, the rest as CAG long (CAGL); and GGN short (GGNS) if GGN repeat lengths ≤ 23, or long if > 23 (GGNL). CAGS and GGNS were associated with lower adiposity than CAGL or GGNL (P < 0.05). There was an association between the logarithm of CAG repeats polymorphism and the changes of body mass (r = 0.34, P = 0.03). At adult age, CAGS men showed lower accumulation of total body and trunk fat mass, and lower resting metabolic rate (RMR) and MFO per kg of total lean mass compared with CAGL (P < 0.05). GGNS men also showed lower percentage of body fat (P < 0.05). In summary, androgen receptor CAG and GGN repeat polymorphisms are associated with RMR, MFO, fat mass, and its regional distribution in healthy male adolescents, influencing fat accumulation from adolescence to adult age.
- Open Access
- 8 July 2014
- Published by Impact Journals, LLC in Oncotarget
- Vol. 5 (15) , 6206-6217
Microsatellite instability and ploidy status define three categories with distinctive prognostic impact in endometrioid endometrial cancer
Microsatellite instability (MSI) and aneuploidy are inversely related phenomena. We tested whether ploidy status influences the clinical impact of MSI in endometrioid endometrial cancer (EEC). We analyzed 167 EECs for MSI and ploidy. Tumors were classified in three categories according to MSI and ploidy status. Associations with clinicopathological and molecular variables, survival, and treatment response were assessed.
- 8 July 2014
- Published by Impact Journals, LLC in Oncotarget
- Vol. 5 (15) , 6206-6217
Open AccessMicrosatellite instability and ploidy status define three categories with distinctive prognostic impact in endometrioid endometrial cancer
Microsatellite instability (MSI) and aneuploidy are inversely related phenomena. We tested whether ploidy status influences the clinical impact of MSI in endometrioid endometrial cancer (EEC). We analyzed 167 EECs for MSI and ploidy. Tumors were classified in three categories according to MSI and ploidy status. Associations with clinicopathological and molecular variables, survival, and treatment response were assessed.
- Open Access
- 19 July 2012
- Published by MDPI AG in Pharmaceuticals
- Vol. 5 (7) , 758-778
The Influence of Estrogens on the Biological and Therapeutic Actions of Growth Hormone in the Liver
GH is main regulator of body growth and composition, somatic development, intermediate metabolism and gender-dependent dimorphism in mammals. The liver is a direct target of estrogens because it expresses estrogen receptors which are connected with development, lipid metabolism and insulin sensitivity, hepatic carcinogenesis, protection from drug-induced toxicity and fertility. In addition, estrogens can modulate GH actions in liver by acting centrally, regulating pituitary GH secretion, and, peripherally, by modulating GHR-JAK2-STAT5 signalling pathway. Therefore, the interactions of estrogens with GH actions in liver are biologically and clinically relevant because disruption of GH signaling may cause alterations of its endocrine, metabolic, and gender differentiated functions and it could be linked to dramatic impact in liver physiology during development as well as in adulthood. Finally, the interplay of estrogens with GH is relevant because physiological roles these hormones have in human, and the widespread exposition of estrogen or estrogen-related compounds in human. This review highlights the importance of these hormones in liver physiology as well as how estrogens modulate GH actions in liver which will help to improve the clinical use of these hormones.
- 19 July 2012
- Published by MDPI AG in Pharmaceuticals
- Vol. 5 (7) , 758-778
Open AccessThe Influence of Estrogens on the Biological and Therapeutic Actions of Growth Hormone in the Liver
GH is main regulator of body growth and composition, somatic development, intermediate metabolism and gender-dependent dimorphism in mammals. The liver is a direct target of estrogens because it expresses estrogen receptors which are connected with development, lipid metabolism and insulin sensitivity, hepatic carcinogenesis, protection from drug-induced toxicity and fertility. In addition, estrogens can modulate GH actions in liver by acting centrally, regulating pituitary GH secretion, and, peripherally, by modulating GHR-JAK2-STAT5 signalling pathway. Therefore, the interactions of estrogens with GH actions in liver are biologically and clinically relevant because disruption of GH signaling may cause alterations of its endocrine, metabolic, and gender differentiated functions and it could be linked to dramatic impact in liver physiology during development as well as in adulthood. Finally, the interplay of estrogens with GH is relevant because physiological roles these hormones have in human, and the widespread exposition of estrogen or estrogen-related compounds in human. This review highlights the importance of these hormones in liver physiology as well as how estrogens modulate GH actions in liver which will help to improve the clinical use of these hormones.
- Open Access
- 8 July 2012
- Published by Wiley in Journal of Andrology
- Vol. 33 (4) , 644-650
Androgen Receptor Gene Polymorphisms and the Fat‐Bone Axis in Young Men and Women
Androgen receptor (AR) CAGn (polyglutamine) and GGNn(polyglycine) repeat polymorphisms determine part of the androgenic effect and may influence adiposity. The association of fat mass, and its regional distribution, with the AR CAGn and GGNn polymorphisms was studied in 319 and 78 physically active nonsmoker men and women (mean ± SD: 28.3 ± 7.6 and 24.8 ± 6.2 years old, respectively). The length of CAG and GGN repeats was determined by polymerase chain reaction and fragment analysis, and confirmed by DNA sequencing of selected samples. Men were grouped as CAG short (CAGS) if harboring repeat lengths ≤21, the rest as CAG long (CAGL). The corresponding cutoff CAG number for women was 22. GGN was considered short (GGNS) if GGN ≤23, the rest as GGN long (GGNL). No association between AR polymorphisms and adiposity or the hormonal variables was observed in men. Neither was there a difference in the studied variables between men harboring CAGL + GGNL,CAGS + GGNS,CAGS + GGNL, and CAGL + GGNS combinations. However, in women, GGNn was linearly related to the percentage of body fat (r = 0.30, P < .05), the percentage of fat in the trunk (r = 0.28, P < .05), serum leptin concentration (r = 0.40, P < .05), and serum osteocalcin concentration (r = 0.32, P < .05). In men, free testosterone was inversely associated with adiposity and serum leptin concentration, and positively with osteocalcin, even after accounting for differences in CAGn, GGNn, or both. In summary, this study shows that the AR repeat polymorphism has little influence on absolute and relative fat mass or its regional distribution in physically active men. In young women, GGN length is positively associated with adiposity, leptin, and osteocalcin.
- 8 July 2012
- Published by Wiley in Journal of Andrology
- Vol. 33 (4) , 644-650
Open AccessAndrogen Receptor Gene Polymorphisms and the Fat‐Bone Axis in Young Men and Women
Androgen receptor (AR) CAGn (polyglutamine) and GGNn(polyglycine) repeat polymorphisms determine part of the androgenic effect and may influence adiposity. The association of fat mass, and its regional distribution, with the AR CAGn and GGNn polymorphisms was studied in 319 and 78 physically active nonsmoker men and women (mean ± SD: 28.3 ± 7.6 and 24.8 ± 6.2 years old, respectively). The length of CAG and GGN repeats was determined by polymerase chain reaction and fragment analysis, and confirmed by DNA sequencing of selected samples. Men were grouped as CAG short (CAGS) if harboring repeat lengths ≤21, the rest as CAG long (CAGL). The corresponding cutoff CAG number for women was 22. GGN was considered short (GGNS) if GGN ≤23, the rest as GGN long (GGNL). No association between AR polymorphisms and adiposity or the hormonal variables was observed in men. Neither was there a difference in the studied variables between men harboring CAGL + GGNL,CAGS + GGNS,CAGS + GGNL, and CAGL + GGNS combinations. However, in women, GGNn was linearly related to the percentage of body fat (r = 0.30, P < .05), the percentage of fat in the trunk (r = 0.28, P < .05), serum leptin concentration (r = 0.40, P < .05), and serum osteocalcin concentration (r = 0.32, P < .05). In men, free testosterone was inversely associated with adiposity and serum leptin concentration, and positively with osteocalcin, even after accounting for differences in CAGn, GGNn, or both. In summary, this study shows that the AR repeat polymorphism has little influence on absolute and relative fat mass or its regional distribution in physically active men. In young women, GGN length is positively associated with adiposity, leptin, and osteocalcin.
- 1 July 2012
- Published by SAGE Publications in The International Journal of Biological Markers
- Vol. 27 (3) , 219-226
Microsatellite polymorphism in the EGFR, NOTCH4 and E2F4 genes and their association with breast cancer risk
Background: The sequences of many human genes that encode proteins involved in cancer contain polymorphic microsatellites. Variations in microsatellite length may constitute risk factors in several human diseases, a possibility that has been little explored in breast cancer. Among the genes that contain polymorphic microsatellites are EGFR, NOTCH4 and E2F4. The length of some of these microsatellites has been associated with breast cancer risk. Purpose and methods: To determine whether the length of the microsatellites (CA)n in EGFR, (CTG)n in NOTCH4 and (AGC)n in E2F4 was associated with breast cancer risk, we genotyped these 3 microsatellites in 212 women with breast cancer and a control group of 308 women from the general population who did not have this disease. Results and conclusions: The allelic distribution observed for the 3 microsatellites matched that found in other white populations, with the exception of some (AGC)n alleles in E2F4, which have not been described previously. The length of (CA)n in EGFR and (CTG)n in NOTCH4 was not associated with breast cancer (OR=0.99; 95% CI 0.59–1.37; p=0.619 and OR=1.08; 95% CI 0.71–1.65; p=0.725, respectively). Short alleles (<13 repeats) of (AGC)n in E2F4 were less frequent in women with cancer than in the control sample.
- 1 July 2012
- Published by SAGE Publications in The International Journal of Biological Markers
- Vol. 27 (3) , 219-226
Microsatellite polymorphism in the EGFR, NOTCH4 and E2F4 genes and their association with breast cancer risk
Background: The sequences of many human genes that encode proteins involved in cancer contain polymorphic microsatellites. Variations in microsatellite length may constitute risk factors in several human diseases, a possibility that has been little explored in breast cancer. Among the genes that contain polymorphic microsatellites are EGFR, NOTCH4 and E2F4. The length of some of these microsatellites has been associated with breast cancer risk. Purpose and methods: To determine whether the length of the microsatellites (CA)n in EGFR, (CTG)n in NOTCH4 and (AGC)n in E2F4 was associated with breast cancer risk, we genotyped these 3 microsatellites in 212 women with breast cancer and a control group of 308 women from the general population who did not have this disease. Results and conclusions: The allelic distribution observed for the 3 microsatellites matched that found in other white populations, with the exception of some (AGC)n alleles in E2F4, which have not been described previously. The length of (CA)n in EGFR and (CTG)n in NOTCH4 was not associated with breast cancer (OR=0.99; 95% CI 0.59–1.37; p=0.619 and OR=1.08; 95% CI 0.71–1.65; p=0.725, respectively). Short alleles (<13 repeats) of (AGC)n in E2F4 were less frequent in women with cancer than in the control sample.